Healthlead PCL

Healthlead PCL maintains a relatively strong capital structure with a debt-to-equity ratio of 0.33, indicating a conservative leverage position compared to industry norms. The company's liquidity is assessed as medium, with a current ratio of 3.4, suggesting it can cover short-term obligations but with limited cash reserves. However, the company's net cash position is negative after subtracting total debt, which may signal potential liquidity constraints. In terms of profitability, Healthlead PCL reports a return on equity of 8.05% and a return on assets of 5.07%. These figures are in line with the industry's preferred metrics, indicating that the company is generating returns that are comparable to its peers. The operating margin, derived from the operating income of 110,406,180 THB on revenue of 2,228,851,530 THB, suggests a moderate level of operational efficiency. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification may expose the company to regional economic fluctuations. Healthlead PCL's growth trajectory is supported by a positive free cash flow of 91,131,010 THB and a capital expenditure of -33,201,500 THB, indicating that the company is generating more cash than it is investing in capital assets. The outlook for the current fiscal year suggests continued revenue growth, although specific numeric deltas are not provided in the available data. The risk assessment for Healthlead PCL indicates a low potential for dilution, with no significant dilution sources identified in the available documents. The company's liquidity risk is moderate, primarily due to the negative net cash position after accounting for total debt. No recent events, such as filings or transcripts, are provided in the available data to further assess the company's risk profile.